Examination of ancestral informative markers and self-reported race with tumor characteristics of breast cancer among Black and White women
- PMID: 22648732
- PMCID: PMC3697473
- DOI: 10.1007/s10549-012-2099-0
Examination of ancestral informative markers and self-reported race with tumor characteristics of breast cancer among Black and White women
Abstract
African American (AA) women have a higher mortality from breast cancer (BC) compared to European American (EA) women. This may be due to the higher proportion of AA women with tumors that are diagnosed at more advanced stages and are characterized as being estrogen receptor negative (ER-)/progesterone receptor negative (PR-). Our study sought to determine whether self-reported race and percent African ancestry were associated with BC tumor characteristics. In a multi-center, population-based case-control study of BC, we determined percent African ancestry using ancestry informative markers (AIM) among women self-reporting race as AA or Black. BC tumor characteristics were associated with self-reported race (including a 30 % reduction in ER+/PR+ tumors [95 % confidence interval [CI]: 0.6-0.9] and a 1.5-fold increased risk of high grade [95 % CI: 1.2-1.9] for AA women compared to EA women). AIMs among AA women were not associated with BC tumor characteristics (AA women with ≥95 % versus <80 % African ancestry, odds ratio [OR] = 1.0 for ER+/PR+ [95 % CI: 0.6-1.8] and OR = 0.9 for high-grade tumors [95 % CI: 0.6-1.4]). Similar findings were observed for BC stage. While BC subtypes were associated with self-reported race, BC subtypes were not associated with percent African ancestry. These study results suggest that subtle differences in percent African ancestry are less important than the overall presence of African ancestry in relation to BC tumor characteristics.
Figures
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29. - PubMed
-
- Ademuyiwa FO, et al. Breast cancer racial disparities: unanswered questions. Cancer Res. 2011;71(3):640–4. - PubMed
-
- Morris GJ, Mitchell EP. Higher incidence of aggressive breast cancers in African-American women: a review. J Natl Med Assoc. 2008;100(6):698–702. - PubMed
-
- Li CI, Malone KE, Daling JR. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev. 2002;11(7):601–7. - PubMed
-
- Simon MS, et al. Breast cancer risk estimates for relatives of white and African American women with breast cancer in the Women's Contraceptive and Reproductive Experiences Study. J Clin Oncol. 2006;24(16):2498–504. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01 HD 3-3175/HD/NICHD NIH HHS/United States
- N01 HD033175/HD/NICHD NIH HHS/United States
- P30 CA015704/CA/NCI NIH HHS/United States
- Y01 HD007022/HD/NICHD NIH HHS/United States
- R03 CA 123584/CA/NCI NIH HHS/United States
- T32 CA009168/CA/NCI NIH HHS/United States
- N01 HD033174/HD/NICHD NIH HHS/United States
- 2 T32 CA 09168/CA/NCI NIH HHS/United States
- N01 HD033176/HD/NICHD NIH HHS/United States
- N01 HD023166/HD/NICHD NIH HHS/United States
- R01 AG014358/AG/NIA NIH HHS/United States
- N01 HD 2-3166/HD/NICHD NIH HHS/United States
- K99 NR012232/NR/NINR NIH HHS/United States
- N01 HD 3-3174/HD/NICHD NIH HHS/United States
- R24 HD042828/HD/NICHD NIH HHS/United States
- N01 HD033168/HD/NICHD NIH HHS/United States
- R03 CA123584/CA/NCI NIH HHS/United States
- N01 HD 3-3168/HD/NICHD NIH HHS/United States
- K99 NR 012232/NR/NINR NIH HHS/United States
- N01 HD-3-3176/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
